Latest news
Loading news…
Aeglea BioTherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Austin, Texas, United States Founded 2013 51-100 employees For Profit
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
37
Ticker
AGLE
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- AGLE
- Exchange
- NASDAQ
- IPO date
- Apr 7, 2016
- Raised at IPO
- $50M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- Active products
- 13
Company Info
- Founded
- 2013
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 61
- HQ
- Austin, Texas, United States
- Region
- Southern US
- Exit date
- Apr 7, 2016
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.6
- Trend (90d)
- -0.5
- Last layoff mention
- Apr 12, 2023
Acquisitions by Aeglea BioTherapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Aeglea BioTherapeutics
Director
Vice President of Manufacturing
VP Research & Development
Chief Business Officer
37
professional contacts at Aeglea BioTherapeutics
Contact execs at Aeglea BioTherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Aeglea BioTherapeutics
Loading news…
FAQs about Aeglea BioTherapeutics
People who checked this page also checked these
Sectors Aeglea BioTherapeutics invests & acquires in
Browse the full Acquirezy directory.